Technical Analysis for FULC - Fulcrum Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 4.72 -1.05% -0.05
FULC closed down 1.05 percent on Thursday, October 17, 2019, on 35 percent of normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Down Down
See historical FULC trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -1.05%
New 52 Week Low Weakness -1.05%
Wide Bands Range Expansion -1.05%

Older signals for FULC ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule that are developing for the treatment of facioscapulohumeral muscular dystrophy, a rare, progressive, and disabling muscle wasting disorder that leads to significant physical impairments and disability; and FTX-HbF, a small molecule designed to upregulate fetal hemoglobin in patients with sickle cell disease and b-thalassemia. Fulcrum Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts.
Medicine Biopharmaceutical Medical Specialties Diseases Muscular Dystrophy Infancy Sickle Cell Disease Disorder Facioscapulohumeral Muscular Dystrophy Hemoglobins
Is FULC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.94
52 Week Low 4.6
Average Volume 64,419
200-Day Moving Average 0.0
50-Day Moving Average 8.9712
20-Day Moving Average 6.4345
10-Day Moving Average 5.433
Average True Range 0.7913
ADX 47.35
+DI 5.3234
-DI 27.2679
Chandelier Exit (Long, 3 ATRs ) 7.531099999999999
Chandelier Exit (Short, 3 ATRs ) 6.9739
Upper Bollinger Band 8.8916
Lower Bollinger Band 3.9774
Percent B (%b) 0.15
BandWidth 76.372679
MACD Line -1.3186
MACD Signal Line -1.2861
MACD Histogram -0.0325
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.38
Resistance 3 (R3) 5.41 5.23 5.27
Resistance 2 (R2) 5.23 5.06 5.21 5.23
Resistance 1 (R1) 4.97 4.95 4.88 4.94 5.20
Pivot Point 4.79 4.79 4.74 4.77 4.79
Support 1 (S1) 4.53 4.62 4.44 4.50 4.24
Support 2 (S2) 4.35 4.51 4.33 4.21
Support 3 (S3) 4.09 4.35 4.17
Support 4 (S4) 4.06